Peripheral artery angioplasty is a minimally invasive procedure that helps restore blood flow in narrowed or blocked arteries of the legs and arms, offering relief from pain and helping prevent serious complications.

Opening Pathways to Better Circulation

When fatty deposits called plaque build up inside the arteries that supply blood to your legs, arms, or pelvis, blood flow becomes restricted. This buildup, known as atherosclerosis, can cause pain, numbness, and other troubling symptoms that interfere with daily life. Peripheral artery angioplasty is a treatment designed to widen these narrowed blood vessels and restore normal circulation. The main goal is to improve symptoms such as leg pain during walking, help wounds heal better, and reduce the risk of serious problems like heart attack or stroke.^[1]

Treatment decisions depend on how severe the blockage is, where it’s located, and how much it affects your ability to perform everyday activities. Doctors may first try lifestyle changes and medications, but when symptoms persist or worsen, procedures like angioplasty become necessary. The approach is tailored to each person’s unique situation, considering factors such as overall health, the extent of artery narrowing, and whether other medical conditions like diabetes or kidney disease are present.^[3]

The treatment landscape includes both well-established methods approved by medical societies and ongoing research into newer therapies. Standard treatments have been refined over many years and are supported by clinical guidelines from organizations worldwide. At the same time, researchers continue to explore innovative approaches in clinical trials, testing new materials, devices, and techniques that may improve outcomes for people with peripheral artery disease. Understanding the full range of options helps patients and doctors work together to find the most appropriate path forward.^[4]

Standard Treatment Approaches

Peripheral artery angioplasty involves using a tiny medical balloon to push plaque against the artery walls, creating more space for blood to flow through. The procedure begins with the insertion of a thin, flexible tube called a catheter into an artery, usually through a small puncture in the groin area or sometimes the wrist. The doctor uses live X-ray imaging to guide the catheter to the exact location of the blockage. A special dye is injected to make the arteries visible on the X-ray screen, allowing the doctor to see precisely where the narrowing occurs.^[1]

Once the catheter is properly positioned, a second catheter with a deflated balloon at its tip is threaded through to the blocked area. When the balloon reaches the narrowed section, it is inflated with contrast fluid. This inflation presses the plaque firmly against the artery walls, widening the blood vessel and improving blood flow. The pressure from the balloon essentially reshapes the inner channel of the artery, making more room for blood to pass through. After the artery has been widened, the balloon is deflated and removed, along with all the wires and catheters used during the procedure.^[5]

In many cases, doctors also place a stent during the angioplasty. A stent is a small tube made of metal mesh that acts like a scaffold to keep the artery open after the balloon has done its work. The stent is mounted on the balloon catheter and expands when the balloon inflates. Unlike the balloon, the stent stays permanently in place after the procedure is complete. It helps prevent the artery from narrowing again, a problem called restenosis, which can occur when plaque builds up again or the artery walls recoil. Stenting is particularly useful for long blockages or arteries with heavy calcification.^[4]

The procedure can be performed on various arteries depending on where the blockage is located. Common treatment sites include the aorta (the main artery coming from the heart), arteries in the hip or pelvis, the femoral artery in the thigh, the popliteal artery behind the knee, and smaller arteries in the lower leg. The location and extent of the blockage help determine the best approach and whether additional techniques might be needed.^[1]

Most people remain awake during the procedure but receive medication to help them relax and prevent pain. Local anesthesia numbs the area where the catheter enters the body, so patients typically feel no discomfort during the actual procedure. The entire process usually takes one to three hours. Many patients go home the same day or after an overnight hospital stay, making it much less invasive than traditional bypass surgery, which requires larger incisions and longer recovery times.^[3]

Recovery after peripheral artery angioplasty usually involves a few days of limited activity. Patients may notice a small bruise or lump at the site where the catheter was inserted, and the area may feel tender for several days. Light activities at home are generally fine, but strenuous exercise, heavy lifting, and climbing stairs should be avoided for at least one to two weeks, or until the doctor gives approval. Walking is encouraged and often recommended as part of recovery, starting slowly and gradually increasing distance each day.^[16]

Lifestyle modifications play a crucial role in preventing the treated artery from narrowing again. Quitting smoking is perhaps the most important step, as smoking significantly increases the risk of plaque buildup and makes the disease progress faster. Following a heart-healthy diet rich in fruits, vegetables, and whole grains while limiting saturated fats helps control cholesterol levels. Regular exercise, particularly walking, not only aids recovery but also improves overall circulation and reduces symptoms over time.^[14]

Medications are an essential component of standard treatment. Many patients receive blood thinners to prevent clot formation after the procedure. Statins are commonly prescribed to help lower cholesterol levels by reducing the liver’s production of LDL cholesterol, often called “bad cholesterol.” These medications can cause side effects such as indigestion, headaches, nausea, or muscle aches, though many people tolerate them well. Antihypertensives, particularly angiotensin-converting enzyme (ACE) inhibitors, may be prescribed to control high blood pressure. These work by blocking hormones that raise blood pressure, helping protect the arteries from further damage. Common side effects include dizziness, tiredness, headaches, and a persistent dry cough, though most side effects improve after a few days.^[14]

Antiplatelet medications or anticoagulants are often prescribed to prevent blood clots from forming in the treated artery. These medicines reduce the likelihood that a piece of plaque could break loose and cause a blockage elsewhere in the body. Patients taking these medications need to follow their doctor’s instructions carefully, as blood thinners can increase the risk of bleeding. Regular follow-up appointments allow doctors to monitor the treated arteries and adjust medications as needed.^[14]

As with any medical procedure, peripheral artery angioplasty carries some risks. Potential complications include allergic reactions to contrast dye or medications used in drug-coated stents, bleeding or clotting at the catheter insertion site, blood clots forming in the legs or lungs, damage to blood vessels or nerves, heart attack, infection at the surgical site, kidney problems (especially in people with existing kidney disease), stent misplacement, stroke, or failure to successfully open the blocked artery. In rare cases, complications may be severe enough to require emergency surgery or result in limb loss.^[1]

Treatment in Clinical Trials

While standard angioplasty and stenting have proven effective, researchers continue to investigate ways to improve outcomes and reduce the rate at which arteries narrow again after treatment. One significant area of innovation involves drug-eluting stents (DES) and drug-coated balloons (DCB). Unlike traditional bare metal stents, these devices are coated with medications that slowly release over time to prevent the development of neointimal hyperplasia, a process where new tissue grows inside the artery and causes it to narrow again. The medications used typically target cell growth and inflammation in the artery walls.^[4]

Clinical trials have compared drug-eluting stents and drug-coated balloons to conventional balloon angioplasty and bare metal stents in patients with peripheral artery disease of the lower limbs. Results from these studies have generally shown better outcomes with the drug-coated devices. Patients treated with drug-eluting technologies tend to experience longer-lasting improvements in blood flow and reduced rates of restenosis. This means the treated arteries stay open longer, and patients may require fewer repeat procedures. The medications on these devices work by interfering with the biological processes that cause tissue to grow back into the artery channel.^[4]

Another technique being explored in clinical research is atherectomy, which physically removes plaque from the artery rather than just compressing it. Atherectomy devices can include sharp blades, grinders, or lasers mounted on a catheter. This approach may be used before balloon angioplasty to clear away hard, calcified plaque that would be difficult to compress with a balloon alone. In some cases, atherectomy can be used when standard angioplasty isn’t possible due to the location or hardness of the blockage. Trials are ongoing to determine which patients benefit most from atherectomy and how it compares to balloon-based approaches in different situations.^[13]

Research is also examining the optimal use of stents versus drug-coated balloons. Some studies suggest that for certain types of blockages, particularly in smaller arteries or shorter segments of narrowing, drug-coated balloons alone might provide good results without leaving a permanent metal stent in the artery. This could be advantageous because it preserves the artery for potential future treatments and avoids long-term complications associated with permanent implants. However, stents may still be necessary for long blockages, heavily calcified arteries, or when initial balloon results are not satisfactory.^[4]

Clinical trials for peripheral artery disease typically progress through several phases. Phase I trials focus primarily on safety, testing new devices or techniques in small groups of patients to identify potential risks and determine appropriate dosing or usage parameters. Phase II trials expand to larger groups and begin evaluating effectiveness, looking at whether the new treatment improves blood flow, reduces symptoms, or prevents restenosis better than existing methods. Phase III trials are large-scale studies that compare the new treatment directly to the current standard of care, providing the evidence needed for regulatory approval and clinical guideline updates.^[4]

Eligibility for clinical trials varies depending on the specific study design and the intervention being tested. Generally, participants must have documented peripheral artery disease with symptoms that interfere with daily activities or threaten limb health. Some trials focus on specific patient populations, such as those with diabetes, kidney disease, or particularly complex blockages. Geographic location matters too, as trials are conducted at specific medical centers, which may be in the United States, Europe, or other regions. Interested patients should discuss trial opportunities with their vascular specialist to learn about studies that might be appropriate for their situation.^[4]

Preliminary results from various clinical trials have shown promising trends. Drug-coated technologies have demonstrated improvements in key clinical parameters such as the rate at which treated arteries remain open over time, measured as patency rates. Some studies have reported reductions in the need for repeat procedures within the first year or two after treatment. Patients in these trials often experience sustained improvements in walking ability and leg pain, along with better wound healing in cases where tissue damage had occurred. Safety profiles have generally been acceptable, with most adverse events being similar to those seen with standard treatments.^[4]

Research continues to address the challenge of restenosis, which remains a significant limitation even with improved technologies. Scientists are investigating different drug formulations, coating materials, and delivery mechanisms to find the optimal balance between effectiveness and safety. Some studies are exploring combinations of treatments, such as using atherectomy followed by drug-coated balloons, to see if combining approaches produces better results than either technique alone. Understanding how different plaque compositions, artery locations, and patient characteristics affect outcomes helps researchers refine treatment strategies.^[4]

The mechanisms by which drug-coated devices work involve affecting specific molecular pathways involved in cell growth and inflammation. The medications typically used include anti-proliferative agents that prevent smooth muscle cells in the artery walls from multiplying excessively. When these cells multiply and migrate, they can narrow the artery channel again, causing symptoms to return. By controlling this process, drug-coated devices help maintain the opening created during angioplasty. Researchers continue to study the optimal drug doses, release rates, and duration of drug delivery to maximize benefits while minimizing any potential systemic effects.^[4]

Most common treatment methods

• Balloon angioplasty
  • A medical balloon is inserted through a catheter and inflated at the site of blockage to press plaque against artery walls and widen the blood vessel
  • The procedure is done under local anesthesia with sedation, and patients typically remain awake
  • Most commonly performed on arteries in the legs, pelvis, hips, thighs, and lower legs
  • Can be performed using plain balloons or drug-coated balloons that release medication to prevent restenosis
• Stent placement
  • A small metal mesh tube is placed in the artery to keep it open after balloon angioplasty
  • Stents expand when the balloon inflates and remain permanently in place
  • Bare metal stents provide structural support without medication
  • Drug-eluting stents are coated with medications that slowly release to prevent tissue regrowth and narrowing
  • Particularly useful for long or calcified blockages where arteries might narrow again quickly
• Atherectomy
  • Uses special devices to physically remove plaque from inside the artery rather than just compressing it
  • Devices may include sharp blades, grinders, or lasers mounted on catheters
  • Often used before balloon angioplasty to clear hard, calcified plaque
  • May be an option when standard balloon angioplasty is not possible due to plaque location or characteristics
• Medications
  • Blood thinners (antiplatelet drugs or anticoagulants) prevent clot formation in treated arteries
  • Statins reduce cholesterol production by the liver, helping prevent further plaque buildup
  • ACE inhibitors control blood pressure by blocking hormones that constrict blood vessels
  • Medications to improve blood flow and reduce leg pain during walking may be prescribed
• Lifestyle modifications
  • Smoking cessation is critical to prevent disease progression and improve treatment outcomes
  • Regular walking exercise using a “stop-start” method helps improve symptoms and build endurance
  • Heart-healthy diet emphasizing fruits, vegetables, whole grains, and limiting saturated fats
  • Proper diabetes management through diet and medications to prevent worsening of artery disease
  • Supervised exercise therapy programs that provide structured, monitored physical activity